Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

3 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

9(56.3%)

Phase 2

3(18.8%)

Phase 3

2(12.5%)

Phase 4

1(6.3%)

Phase 1

1(6.3%)

16Total

N/A(9)

Phase 2(3)

Phase 3(2)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials

NCT05394207Not ApplicableUnknown

Evaluation Of The Effect Of L. Casei DG® On Vitamin D Absorption In Patients Under Vitamin D Supplementation.

Role: lead

NCT03720119Completed

Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®

Role: lead

NCT04202692Not ApplicableCompleted

Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment

Role: lead

NCT03883074Not ApplicableCompleted

Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease

Role: lead

NCT03449628Not ApplicableCompleted

L. Casei DG® in Patients With Irritable Bowel Syndrome.

Role: lead

NCT04873063Phase 1Completed

Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers

Role: lead

NCT03793556Not ApplicableCompleted

Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor

Role: lead

NCT03434249Not ApplicableCompleted

Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic

Role: lead

NCT02988791Not ApplicableCompleted

Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC)

Role: collaborator

NCT03093675Not ApplicableCompleted

Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot Study

Role: lead

NCT02077777Phase 2Completed

Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.

Role: lead

NCT02371499Not ApplicableCompleted

Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study

Role: lead

NCT02338505Phase 2Unknown

Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX

Role: collaborator

NCT02077699Phase 4Completed

Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study

Role: lead

NCT01120340Phase 3Completed

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares

Role: lead

NCT00626288Phase 3Completed

Mesalazine Therapy in Patients With Irritable Bowel Syndrome

Role: lead

NCT00774007Phase 2Completed

A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome

Role: lead

All 17 trials loaded